Large Trader AI

Xylem Inc (XYL)

IndustrialsSpecialty Industrial MachineryUndervalued

Price: $94.18 · Nov 13, 2026Analysis of Nov 10, 2026

Fair value

Fair value · Low
$96.43
Fair value · Mid
$120.53
Fair value · High
$144.64

Scorecard

Five subjects rated by the server with fixed thresholds. No overall grade: each colour shows where the strength or the weakness is.

Financial strengthStrong4 good · 0 neutral · 0 weak
ProfitabilityStrong3 good · 1 neutral · 0 weak
Earnings qualityAverage1 good · 1 neutral · 1 weak
GrowthStrong4 good · 0 neutral · 0 weak
ValuationUndervalued
Insolvency riskLow0.1% (estimate of the Ohlson model, 1-2 years)

Altman zone: Safe (Z 3.2) · annual report of Dec 31, 2025

Price and fair valueValue (USD)PriceFair value

Undervalued

Price and fair value100200Nov 30, 2015May 28, 2021Nov 9, 2026+30%+10%-10%-30%

Analysis

Conclusion

Xylem Inc designs, manufactures and services water and wastewater equipment, including pumps, filtration and treatment systems, smart meters and monitoring software, for utility, industrial and building customers. At 99.26 USD on 2026-11-09, the shares give a market capitalisation of 22.76 billion USD and an enterprise value of 24.95 billion USD.

The verdict is fair. Today's price-to-earnings ratio of 21.2 sits well below its ten-year median of 37.1, and enterprise value to EBITDA of 12.9 compares with a median of 20.5. The discounted cash flow gives 77.19 USD per share at a discount rate of 9.86%. The fair value band runs from 96.43 to 144.64 USD, with a midpoint of 120.53 USD and a margin of safety of 21.4% at the current price. The reverse DCF implies growth of 11.1% a year, against a five-year revenue CAGR of 13.1% and a five-year free cash flow per share CAGR of 1.1%.

Three numbers hold the case up: net debt to EBITDA of 1.13x, interest coverage of 36.3x and an Altman Z-score of 3.20. Three numbers weaken it: return on invested capital of 8.9% sits just below the WACC of 9.2%, the share count has grown at 6.1% a year over five years, and next-year EPS estimates have fallen 4.7% over the last 90 days.

Financial health

The financial strength colour is green, supported by net debt to EBITDA of 1.13x, interest coverage of 36.3x, a current ratio of 1.39 and an Altman Z-score of 3.20. The quick ratio is 0.94 and debt to equity is 0.28, so the balance sheet is not reliant on short-term funding. The Altman model was designed mainly for manufacturers. Xylem is an equipment maker, so the model fits reasonably well here, and its Z-score sits in the safe zone. Insolvency risk: low, about 0.1% by the estimate of the Ohlson model over one to two years. Debt has fallen 21.2% a year over the last five years on an annual basis, which further lowers the pressure on cash flow.

Earnings quality

The earnings quality colour is yellow. Free cash flow conversion is strong at 96.9% over five years, but it has eased to 85.8% on a trailing twelve-month basis. The accrual ratio of -1.7% is favourable, because reported earnings are backed by cash. Stock-based compensation is 0.6% of revenue, leaving free cash flow after stock compensation at 866 million USD. The share count has grown 6.1% a year over five years, which is the main weakness. The Piotroski score is 6 out of 9. The Beneish M-score value is not available in the data, so its reading cannot be assessed. The company beat earnings expectations in 7 of the last 8 quarters, with an average surprise of 5.6%. Estimate revisions are negative: current-year EPS estimates are down 4.0% over 90 days, and next-year estimates are down 4.7%.

Profitability

The profitability colour is green. The operating margin is 15.2%, against a ten-year median of 11.3%, and the net margin is 11.9%, against a median of 7.9%. The gross margin of 39.8% is above its median of 38.2%. The operating margin stability figure is 0.1588. Return on invested capital is 8.9%, with a five-year median of 8.1%, against a WACC of 9.2%. The given ROIC minus WACC value is -0.3%, rated neutral. The DuPont split shows a net margin of 10.6%, an asset turnover of 0.51x and an equity multiplier of 1.54x. Return on equity of 10.5% therefore comes mainly from margins, not from leverage.

Growth

The growth colour is green. Revenue has compounded at 17.8% over three years, 13.1% over five years and 9.5% over ten years. Earnings per share have compounded at 26.0%, 22.8% and 7.7% over the same periods. Free cash flow per share grew 20.3% over three years but only 1.1% over five years, and 6.9% over ten. Revenue grew in 9 of the last 10 years. Analysts expect next-year EPS to rise 8.7%, a figure that is lower than the recent three-year pace.

Valuation

The valuation colour is yellow. The price-to-earnings ratio of 21.2 is 42.8% below its ten-year median of 37.1, and the price to book ratio of 2.22 is 54.0% below its median of 4.82. Enterprise value to EBITDA of 12.9 is 37.3% below its median of 20.5. The discounted cash flow gives 77.19 USD per share, using a discount rate of 9.86%, a first-stage growth rate of 9.5% and a terminal growth rate of 2.5%. The terminal value makes up 54.0% of that figure. The fair value from historical multiples is 163.87 USD. The fair value band runs from 96.43 to 144.64 USD with a midpoint of 120.53 USD, and the margin of safety is 21.4%. The reverse DCF implies growth of 11.1% a year. The dividend yield is 1.8%, and dividends absorb 44.0% of free cash flow.

Risks

A fall in return on invested capital below the cost of capital would reduce the value the company creates from its investments, and it is already only slightly below the WACC. Continued share issuance at 6.1% a year would dilute existing shareholders. Falling estimate revisions could signal weaker earnings ahead, and the reverse DCF already assumes 11.1% growth, above the free cash flow per share growth of 1.1% over five years. The discounted cash flow depends heavily on the terminal value, at 54.0% of its result, and the fair value band rests on fixed assumptions rather than a forecast. The Beneish M-score value is not available. This analysis has no debt maturity schedule and no revenue breakdown by segment, so refinancing timing and the performance of individual businesses cannot be assessed.

Metrics

Company
NameXylem Inc
SectorIndustrials
SymbolXYL.US
CountryUSA
CurrencyUSD
IndustrySpecialty Industrial Machinery
DescriptionXylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco brands; and pumps, valves, heat exchangers, controls, and dispensing equipment used for water and focuses on the residential, commercial and industrial markets under the Rule, Bell & Gossett, Flojet, Goulds Water Technology, Jabsco, and Lowara brands. It also provides smart meters, network communication devices, data analytics, test instruments, controls, sensor devices, software and managed services, critical infrastructure services, cloud-based analytics, and remote monitoring and data management under the Ebro, Sensus, Sentec, Smith Blair, WTW, YSI, and Xylem Vue brands. In addition, the company offers preventative maintenance services, rapid response mobile services, digitally enabled/outsourced solutions, process and wastewater treatment systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, continuous deionization, and mobile dewatering equipment
Fiscal year endDecember
Data dates
Price2026-11-09
Statements2026-09-30
Risk free date2026-11-09
Fundamentals fetched at2026-11-06T03:33:07.079Z
Market
Beta0.994
Price99.26
Market cap22,763,751,602
Quote unitUSD
Shares now229,334,592
Risk free rate0.0489
Risk free symbolUS10Y
Enterprise value24,950,751,602
Financial health
Altman z3.2016SAFE
Quick ratio0.9405
Current ratio1.3906OK
Debt to equity0.2819
Net debt to ebitda1.1279OK
Interest coverage36.2895OK
Debt vs revenue growth5y-0.2123
Earnings quality
Beneish › M—
Beneish › Label—
Piotroski › Score6
Piotroski › Passed6
Piotroski › Evaluable9
Fcf after sbc866,000,000
Accrual ratio-0.0166
Sbc to revenue0.0061
Fcf conversion5y0.9685
Fcf conversion ttm0.8575
Share count cagr5y0.0614
Earnings surprises › Beats7
Earnings surprises › Misses1
Earnings surprises › Quarters8
Earnings surprises › Average surprise pct5.6401
Estimate revisions › Next year › Growth0.0869
Estimate revisions › Next year › Change90d-0.0468
Estimate revisions › Next year › Up last30d1
Estimate revisions › Next year › Down last30d6
Estimate revisions › Current year › Change90d-0.0401
Estimate revisions › Current year › Up last30d3
Estimate revisions › Current year › Down last30d4
Profitability
Roic0.0891
Wacc0.092
Dupont › As of2025-12-31
Dupont › Net margin0.1059
Dupont › Asset turnover0.5124
Dupont › Equity multiplier1.5361
Tax rate0.1956
Net margin0.1186
Cost of debt0.0489
Gross margin0.3979
Cost of equity0.0986
Roic median5y0.0807
Roic minus wacc-0.0029NEUTRAL
Return on equity0.1046
Net margin median0.0793
Operating margin0.1515
Gross margin median0.3824
Operating margin median0.1126
Operating margin stability0.1588
Growth
Eps › Cagr3y0.2598
Eps › Cagr5y0.2283
Eps › Cagr10y0.0768
Revenue › Cagr3y0.1784
Revenue › Cagr5y0.1313
Revenue › Cagr10y0.0948
Fcf per share › Cagr3y0.2027
Fcf per share › Cagr5y0.0105
Fcf per share › Cagr10y0.0692
Revenue growth consistency › Growing years9
Revenue growth consistency › Comparable years10
Valuation
Dcf › G10.0948
Dcf › G t0.025
Dcf › Fcf0866,000,000
Dcf › Discount rate0.0986
Dcf › Terminal share0.5403
Dcf › Fair value per share77.1912
Current › Pb2.2167
Current › Pe21.1953
Current › Ps2.5128
Current › P fcf24.7163
Current › Fcf yield0.0405
Current › Ev to ebitda12.8678
Current › Earnings yield0.0472
VerdictFAIR
Fair value › Low96.4259
Fair value › Mid120.5324
Fair value › High144.6388
Fair value › Margin of safety0.2143
Historical › Pb › Median4.8165
Historical › Pb › Points10
Historical › Pb › Current2.2167
Historical › Pb › Premium pct-0.5398
Historical › Pe › Median37.0817
Historical › Pe › Points10
Historical › Pe › Current21.1953
Historical › Pe › Premium pct-0.4284
Historical › Ps › Median3.2667
Historical › Ps › Points10
Historical › Ps › Current2.5128
Historical › Ps › Premium pct-0.2308
Historical › P fcf › Median33.9689
Historical › P fcf › Points10
Historical › P fcf › Current24.7163
Historical › P fcf › Premium pct-0.2724
Historical › Ev to ebitda › Median20.51
Historical › Ev to ebitda › Points10
Historical › Ev to ebitda › Current12.8678
Historical › Ev to ebitda › Premium pct-0.3726
Reverse dcf › Implied growth0.1114
Reverse dcf › Vs revenue cagr5y-0.0199
Reverse dcf › Vs fcf per share cagr5y0.1009
Historical fair value163.8735
Dividend
Yield0.0178
Payout on fcf0.4397
Forward yield0.017
Data flags
Prices staleNo
Risk free staleNo
Fundamentals staleNo

Similar companies